Citadel Advisors LLC 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:22 pm Sale | 2024-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Citadel Advisors LLC | 21,083 0.000% | -4,265,844 (-99.51%) | Filing |
| 2024-02-14 6:18 pm Purchase | 2023-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Citadel Advisors LLC | 4,286,927 7.900% | 1,390,392 (+48.00%) | Filing |
| 2023-06-12 5:23 pm Purchase | 2023-05-31 | 13G | Lyra Therapeutics, Inc. LYRA | Citadel Advisors LLC | 2,896,535 5.900% | 2,896,535 (New Position) | Filing |